European Multiple Sclerosis Platform November 2014 Newsletter

by Ket Patel | Dec 1, 2014 | All Articles For Neurology, Multiple Sclerosis

Please click here to view the EMSP November 2014 Newsletter

New Developments In Parkinson’s Disease Management: Interviews With The Experts

by Ket Patel | Nov 14, 2014 | All Videos For Neurology, Movement Disorders

APO-go® Apomorphine hydrochloride PRESCRIBING INFORMATION Consult Summary of Product Characteristics before prescribing. Uses Treatment of motor fluctuations (“on-off” phenomena) in patients with Parkinson’s disease which are not sufficiently controlled by oral...

New Developments In Parkinson’s Disease Management: Interviews With The Experts

by Ket Patel | Nov 14, 2014 | All Videos For Neurology, Movement Disorders

APO-go® Apomorphine hydrochloride PRESCRIBING INFORMATION Consult Summary of Product Characteristics before prescribing. Uses Treatment of motor fluctuations (“on-off” phenomena) in patients with Parkinson’s disease which are not sufficiently controlled by oral...

Critical Case Considerations

by Ket Patel | Nov 14, 2014 | All Videos For Neurology, Movement Disorders

APO-go® Apomorphine hydrochloride PRESCRIBING INFORMATION Consult Summary of Product Characteristics before prescribing. Uses Treatment of motor fluctuations (“on-off” phenomena) in patients with Parkinson’s disease which are not sufficiently controlled by oral...

Am Impakt: Apomorphine For Morning Akinesia Trial – Results

by Ket Patel | Nov 14, 2014 | All Videos For Neurology, Movement Disorders

APO-go® Apomorphine hydrochloride PRESCRIBING INFORMATION Consult Summary of Product Characteristics before prescribing. Uses Treatment of motor fluctuations (“on-off” phenomena) in patients with Parkinson’s disease which are not sufficiently controlled by oral...